BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boys JA, Worrell SG, Chandrasoma P, Vallone JG, Maru DM, Zhang L, Blackmon SH, Dickinson KJ, Dunst CM, Hofstetter WL. Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study. J Gastrointest Surg. 2016;20:6-12; discussion 12. [PMID: 26408330 DOI: 10.1007/s11605-015-2950-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 6.1] [Reference Citation Analysis]
Number Citing Articles
1 Jayaprakasam VS, Yeh R, Ku GY, Petkovska I, Fuqua JL 3rd, Gollub M, Paroder V. Role of Imaging in Esophageal Cancer Management in 2020: Update for Radiologists. AJR Am J Roentgenol 2020;215:1072-84. [PMID: 32901568 DOI: 10.2214/AJR.20.22791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Oetzmann von Sochaczewski C, Haist T, Pauthner M, Mann M, Braun S, Ell C, Lorenz D. Infiltration Depth is the Most Relevant Risk Factor for Overall Metastases in Early Esophageal Adenocarcinoma. World J Surg. 2020;44:1192-1199. [PMID: 31853591 DOI: 10.1007/s00268-019-05291-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Weksler B, Kennedy KF, Sullivan JL. Using the National Cancer Database to create a scoring system that identifies patients with early-stage esophageal cancer at risk for nodal metastases. J Thorac Cardiovasc Surg. 2017;154:1787-1793. [PMID: 28867381 DOI: 10.1016/j.jtcvs.2017.07.036] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
4 Künzli HT, Belghazi K, Pouw RE, Meijer SL, Seldenrijk CA, Weusten B, Bergman J. Endoscopic management and follow-up of patients with a submucosal esophageal adenocarcinoma. United European Gastroenterol J 2018;6:669-77. [PMID: 30083328 DOI: 10.1177/2050640617753808] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
5 Gotink AW, Ten Kate FJ, Doukas M, Wijnhoven BP, Bruno MJ, Looijenga LH, Koch AD, Biermann K. Do pathologists agree with each other on the histological assessment of pT1b oesophageal adenocarcinoma? United European Gastroenterol J 2019;7:261-9. [PMID: 31080611 DOI: 10.1177/2050640618817693] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
6 Worrell SG. Esophageal Cancer and Surgical Margins: When a Positive Is a Negative. Ann Surg Oncol 2020;27:1316-7. [PMID: 31900810 DOI: 10.1245/s10434-019-08181-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Saunders JH, Al-Zubaidi S, Waller RC, Ortiz-Fernandez-Sordo J, Parsons SL, Ragunath K, Kaye PV; Trent Oesophago-Gastric Unit. The management and long-term outcomes of endoscopic and surgical treatment of early esophageal adenocarcinoma. Dis Esophagus 2020;33:doz097. [PMID: 32090253 DOI: 10.1093/dote/doz097] [Reference Citation Analysis]
8 Plum PS, Ulase D, Bollschweiler E, Chon S, Berlth F, Zander T, Alakus H, Hölscher AH, Bruns CJ, Schallenberg S, Quaas A, Loeser H. Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus. J Cancer Res Clin Oncol 2018;144:1731-9. [DOI: 10.1007/s00432-018-2698-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Feczko AF, Louie BE. Endoscopic Resection in the Esophagus. Thorac Surg Clin 2018;28:481-97. [PMID: 30268294 DOI: 10.1016/j.thorsurg.2018.07.006] [Reference Citation Analysis]
10 Künzli HT, van Berge Henegouwen MI, Gisbertz SS, van Esser S, Meijer SL, Bennink RJ, Wiezer MJ, Seldenrijk CA, Bergman JJGHM, Weusten BLAM. Pilot-study on the feasibility of sentinel node navigation surgery in combination with thoracolaparoscopic lymphadenectomy without esophagectomy in early esophageal adenocarcinoma patients. Dis Esophagus 2017;30:1-8. [PMID: 28881907 DOI: 10.1093/dote/dox097] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
11 Oza K, Peesay T, Greenspun B, Carroll JE, Shafa S, Zeck JC, Haddad NG, Margolis M, Khaitan PG. Long-term outcomes of endoscopic mucosal resection for early-stage esophageal adenocarcinoma. Surg Endosc 2021. [PMID: 34845554 DOI: 10.1007/s00464-021-08884-2] [Reference Citation Analysis]
12 Molena D, DeMeester SR. The dilemma of T1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg 2017;153:1206-7. [PMID: 28314532 DOI: 10.1016/j.jtcvs.2016.10.106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
13 Graham D, Sever N, Magee C, Waddingham W, Banks M, Sweis R, Al-Yousuf H, Mitchison M, Alzoubaidi D, Rodriguez-Justo M, Lovat L, Novelli M, Jansen M, Haidry R. Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience. World J Gastroenterol 2018; 24(41): 4698-4707 [PMID: 30416317 DOI: 10.3748/wjg.v24.i41.4698] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
14 Schwameis K, Green KM, Worrell SG, Samaan J, Cooper S, Tatishchev S, Oh DS, Hagen JA, DeMeester SR. Outcome with Primary En-bloc Esophagectomy for Submucosal Esophageal Adenocarcinoma. Ann Surg Oncol 2017;24:3921-5. [PMID: 28975518 DOI: 10.1245/s10434-017-6091-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
15 Oetzmann von Sochaczewski C, Haist T, Pauthner M, Mann M, Fisseler-Eckhoff A, Braun S, Ell C, Lorenz D. The overall metastatic rate in early esophageal adenocarcinoma: long-time follow-up of surgically treated patients. Dis Esophagus 2019;32:doy127. [PMID: 30596900 DOI: 10.1093/dote/doy127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Zeki SS, Bergman JJ, Dunn JM. Endoscopic management of dysplasia and early oesophageal cancer. Best Pract Res Clin Gastroenterol 2018;36-37:27-36. [PMID: 30551853 DOI: 10.1016/j.bpg.2018.11.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Mannath J, Ragunath K. Role of endoscopy in early oesophageal cancer. Nat Rev Gastroenterol Hepatol. 2016;13:720-730. [PMID: 27807370 DOI: 10.1038/nrgastro.2016.148] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
18 Belghazi K, Bergman JJGHM, Pouw RE. Management of Nodular Neoplasia in Barrett's Esophagus: Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection. Gastrointest Endosc Clin N Am 2017;27:461-70. [PMID: 28577767 DOI: 10.1016/j.giec.2017.02.004] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
19 Schlottmann F, Patti MG. Current Concepts in Treatment of Barrett's Esophagus With and Without Dysplasia. J Gastrointest Surg 2017;21:1354-60. [PMID: 28353175 DOI: 10.1007/s11605-017-3371-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
20 Schlottmann F, Patti MG, Shaheen NJ. Endoscopic Treatment of High-Grade Dysplasia and Early Esophageal Cancer. World J Surg 2017;41:1705-11. [DOI: 10.1007/s00268-017-3977-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
21 Molena D, DeMeester SR. Response. Gastrointest Endosc 2021;93:284-5. [PMID: 33353636 DOI: 10.1016/j.gie.2020.09.043] [Reference Citation Analysis]
22 Dickinson KJ, Wang K, Zhang L, Allen MS, Cassivi SD, Nichols FC, Shen R, Wigle DA, Blackmon SH. Esophagectomy Outcomes in the Endoscopic Mucosal Resection Era. The Annals of Thoracic Surgery 2017;103:890-7. [DOI: 10.1016/j.athoracsur.2016.08.062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
23 Yin F, Hernandez Gonzalo D, Lai J, Liu X. Histopathology of Barrett’s Esophagus and Early-Stage Esophageal Adenocarcinoma: An Updated Review. GastrointestDisord 2018;1:147-63. [DOI: 10.3390/gidisord1010011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Ilonen IK, Molena D. Gambling with esophageal cancer: May the odds be in your favor! J Thorac Cardiovasc Surg 2018;156:404-5. [PMID: 29576262 DOI: 10.1016/j.jtcvs.2018.02.052] [Reference Citation Analysis]
25 Molena D, Schlottmann F, Boys JA, Blackmon SH, Dickinson KJ, Dunst CM, Hofstetter WL, Lada MJ, Louie BE, Mungo B, Watson TJ, DeMeester SR. Esophagectomy Following Endoscopic Resection of Submucosal Esophageal Cancer: a Highly Curative Procedure Even with Nodal Metastases. J Gastrointest Surg 2017;21:62-7. [PMID: 27561633 DOI: 10.1007/s11605-016-3210-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
26 Boisen ML, Sardesai MP, Kolarczyk L, Rao VK, Owsiak CP, Gelzinis TA. The Year in Thoracic Anesthesia: Selected Highlights From 2017. J Cardiothorac Vasc Anesth 2018;32:1556-69. [PMID: 29655515 DOI: 10.1053/j.jvca.2018.03.001] [Reference Citation Analysis]
27 Schwameis K, Zehetner J, Green KM, DeMeester SR. Workload, Recurrence, Quality of Life and Long-term Efficacy of Endoscopic Therapy for High-grade Dysplasia and Intramucosal Esophageal Adenocarcinoma. Ann Surg 2020;271:701-8. [PMID: 30247330 DOI: 10.1097/SLA.0000000000003038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
28 Molena D, Demeester SR. When less is just less: endoscopic therapy for submucosal T1b esophageal cancer. Gastrointestinal Endoscopy 2020;92:40-3. [DOI: 10.1016/j.gie.2020.03.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Condon A, Muthusamy VR. The evolution of endoscopic therapy for Barrett's esophagus. Ther Adv Gastrointest Endosc 2021;14:26317745211051834. [PMID: 34708204 DOI: 10.1177/26317745211051834] [Reference Citation Analysis]
30 Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P, Cunningham D. Oesophageal cancer. Nat Rev Dis Primers. 2017;3:17048. [PMID: 28748917 DOI: 10.1038/nrdp.2017.48] [Cited by in Crossref: 249] [Cited by in F6Publishing: 246] [Article Influence: 49.8] [Reference Citation Analysis]
31 Boerner T, Molena D. Commentary: Early-stage esophageal cancer: The tip of the iceberg. J Thorac Cardiovasc Surg 2021:S0022-5223(21)01379-9. [PMID: 34629177 DOI: 10.1016/j.jtcvs.2021.09.027] [Reference Citation Analysis]
32 Otaki F, Ma GK, Krigel A, Dierkhising RA, Lewis JT, Blevins CH, Gopalakrishnan NP, Ravindran A, Johnson ML, Leggett CL, Wigle D, Wang KK, Falk GW, Abrams JA, Nakagawa H, Rustgi AK, Wang TC, Lightdale CJ, Ginsberg GG, Iyer PG. Outcomes of patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study. Gastrointest Endosc 2020;92:31-39.e1. [PMID: 31953189 DOI: 10.1016/j.gie.2020.01.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
33 Benech N, O'Brien JM, Barret M, Jacques J, Rahmi G, Perrod G, Hervieu V, Jaouen A, Charissoux A, Guillaud O, Legros R, Walter T, Saurin JC, Rivory J, Prat F, Lépilliez V, Ponchon T, Pioche M. Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low-risk tumours are not associated with lymph node metastases. United European Gastroenterol J 2021;9:362-9. [PMID: 32903167 DOI: 10.1177/2050640620958903] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Greene CL, Worrell SG, Attwood SE, Chandrasoma P, Chang K, DeMeester TR, Lord RV, Montgomery E, Pech O, Vallone J, Vieth M, Wang KK, DeMeester SR. Emerging Concepts for the Endoscopic Management of Superficial Esophageal Adenocarcinoma. J Gastrointest Surg. 2016;20:851-860. [PMID: 26691147 DOI: 10.1007/s11605-015-3056-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
35 DeMeester SR. Response to the Comment on "The Prevalence of Lymph Node Metastases in Patients With T1 Esophageal Adenocarcinoma A Retrospective Review of Esophagectomy Specimens". Ann Surg 2021;274:e106-7. [PMID: 31188223 DOI: 10.1097/SLA.0000000000003373] [Reference Citation Analysis]
36 Gockel I, Hoffmeister A. Endoscopic or Surgical Resection for Gastro-Esophageal Cancer. Dtsch Arztebl Int 2018;115:513-9. [PMID: 30149830 DOI: 10.3238/arztebl.2018.0513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Schölvinck D, Künzli H, Meijer S, Seldenrijk K, van Berge Henegouwen M, Bergman J, Weusten B. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease. Surg Endosc. 2016;30:4102-4113. [PMID: 27357927 DOI: 10.1007/s00464-016-5071-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
38 Worrell SG, Alicuben ET, Oh DS, Hagen JA, DeMeester SR. Accuracy of Clinical Staging and Outcome With Primary Resection for Local-Regionally Limited Esophageal Adenocarcinoma. Ann Surg. 2018;267:484-488. [PMID: 28151801 DOI: 10.1097/sla.0000000000002139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
39 Shen W, Shen Y, Tan L, Jin C, Xi Y. A nomogram for predicting lymph node metastasis in surgically resected T1 esophageal squamous cell carcinoma. J Thorac Dis. 2018;10:4178-4185. [PMID: 30174862 DOI: 10.21037/jtd.2018.06.51] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
40 Watson TJ. Esophagectomy for Superficial Esophageal Neoplasia. Gastrointest Endosc Clin N Am 2017;27:531-46. [PMID: 28577773 DOI: 10.1016/j.giec.2017.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
41 Louie BE. Commentary: Defining low-risk lesions for esophageal preservation informed by resecting the organ. J Thorac Cardiovasc Surg 2020:S0022-5223(20)33204-9. [PMID: 33419551 DOI: 10.1016/j.jtcvs.2020.11.115] [Reference Citation Analysis]
42 Fountoulakis A, Souglakos J, Vini L, Douridas GN, Koumarianou A, Kountourakis P, Agalianos C, Alexandrou A, Dervenis C, Gourtsoyianni S, Gouvas N, Kalogeridi M, Levidou G, Liakakos T, Sgouros J, Sgouros SN, Triantopoulou C, Xynos E. Consensus statement of the Hellenic and Cypriot Oesophageal Cancer Study Group on the diagnosis, staging and management of oesophageal cancer. Updates Surg 2019;71:599-624. [DOI: 10.1007/s13304-019-00696-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Plum PS, Hölscher AH, Pacheco Godoy K, Schmidt H, Berlth F, Chon S, Alakus H, Bollschweiler E. Prognosis of patients with superficial T1 esophageal cancer who underwent endoscopic resection before esophagectomy—A propensity score-matched comparison. Surg Endosc 2018;32:3972-80. [DOI: 10.1007/s00464-018-6139-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
44 Alderson D, Wijnhoven BP. Interventions for Barrett's oesophagus and early cancer. Br J Surg 2016;103:475-6. [PMID: 26898858 DOI: 10.1002/bjs.10135] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]